`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA,
`INC., and AKORN INC.
`Petitioners
`
`v.
`
`SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC.
`Patent Owners
`____________________
`
`Case IPR2016-011311
`Patent 8,648,048
`____________________
`
`
`
`PETITIONER TEVA PHARMACEUTICALS USA, INC’S
` POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`
`1 Cases IPR2017-00585 and IPR2017-00600 have been joined with this
`
`proceeding.
`
`
`
`
`
`Pursuant'tfi37'C.FTR. § 42.10(B)TPEtitiWTe—va—PhMicTal§USATInc.
`
`IPR2016-01131
`
`US. Patent No. 8,648,048
`
`hereby appoints the practitioners of Customer No. 261 1 l as its attorneys to transact
`
`all business in the United States Patent & Trademark Office and Patent Trial and
`
`Appeal Board associated with the above-captioned inter partes review of US.
`
`Patent No. 8,648,048. These practitioners include at least:
`
`Ralph Wilson Powers III (Registration No. 63,504)
`
`Address
`
`STERNE, KESSLER, GOLDSTEIN & Fox P.L.L.C.
`
`l 100 New York Avenue, NW
`
`Washington, DC 20005
`
`202.371 .2600 (reception)
`
`202.37 1 .2540 (facsimile)
`
`
`FOR: Teva Pharmaceuticals USA Inc.
`
`SIGNATURE: M")
`
`.
`
`/
`
`11;)
`
`BY:
`
`(Wk?!
`
`fwn {Hi/S
`
`TITLE: ASSOC-
`
`éfiN‘ffi/K Covwk/
`
`DATE:
`
`’3— [2‘0 [I 9
`
`